Gelteq Ltd
NASDAQ:GELS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pernod Ricard SA
OTC:PDRDF
|
FR |
|
Computer Age Management Services Ltd
NSE:CAMS
|
IN |
Gelteq Ltd
Cash from Operating Activities
Gelteq Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gelteq Ltd
NASDAQ:GELS
|
Cash from Operating Activities
-AU$5.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Cash from Operating Activities
-AU$2.6m
|
CAGR 3-Years
44%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Operating Activities
AU$17.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Operating Activities
AU$125.4m
|
CAGR 3-Years
227%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Operating Activities
-AU$54.8m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Cash from Operating Activities
AU$16.4m
|
CAGR 3-Years
81%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Gelteq Ltd
Glance View
Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
See Also
What is Gelteq Ltd's Cash from Operating Activities?
Cash from Operating Activities
-5.5m
AUD
Based on the financial report for Jun 30, 2025, Gelteq Ltd's Cash from Operating Activities amounts to -5.5m AUD.
What is Gelteq Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-54%
Over the last year, the Cash from Operating Activities growth was -416%. The average annual Cash from Operating Activities growth rates for Gelteq Ltd have been -54% over the past three years .
